Global Polymeric Biomaterials Market size was valued at USD 51.9 Billion in 2023 and is expected to reach USD 165.5 Billion by 2032, at a CAGR of 16.6% during the forecast period 2023 – 2032.

Polymeric Biomaterials Market: Overview

Polymeric biomaterials are made from polymers, which are massive molecules with repeating subunits. These biomaterials are particularly created and manufactured to interact with biological systems for a variety of medical and biomedical purposes.

These are widely used in sectors including regenerative medicine, tissue engineering, medication delivery, medical implants, healing wounds, and diagnostics.

Global trends in the polymeric biomaterials market show an increasing emphasis on biocompatibility, sustainability, and multifunctionality. The growing need for biodegradable materials, fueled by environmental concerns, is driving the development of new biopolymers and bio-based composites.

There is also a growing interest in smart and sensitive biomaterials that can transport drugs and regenerate tissues. Nanotechnology is also making tremendous progress, allowing the creation of nanostructured biomaterials with improved characteristics.

Furthermore, the intersection of fields such as materials science, biotechnology, and nanomedicine is accelerating multidisciplinary research and innovation. Moreover, with an aging population and growing healthcare costs globally, there is a renewed emphasis on creating improved biomaterial options for medical implants and regenerative treatments, resulting in ongoing development in the global polymeric biomaterials market.

By product, polylactic acid segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032. One noticeable development in the polylactic acid (PLA) segment of the polymeric biomaterials market is a greater emphasis on renewable and biodegradable products.

PLA generated from renewable resources provides eco-friendly options for a variety of biomedical applications, in line with the increased emphasis on sustainable development in healthcare.

By application, orthopaedic segment held the highest market share in 2022 and is expected to keep its dominance during the forecast period 2024-2032.

Trends in the orthopedic sector of the polymeric biomaterials market encompass a shift toward bioresorbable implant materials, the development of smart polymers for controlled drug delivery, and the incorporation of nanotechnology to improve material properties which include strength and their biocompatibility ultimately improving the results for patients and surgical techniques.

In North America, renowned trends in the polymeric biomaterials market pertain to a growing emphasis on biodegradable polymers for sustainability, advances in nanotechnologies for specific drug delivery, and the development of 3D printing technologies for tailored medical implants, all of which are driving innovation and growth in the sector.

BASF has spent over 30 years investigating biodegradable, bio-based, and certified compostable biopolymers. The continual development of these high-performance polymers necessitate place amid close collaboration with consumers, research institutes, and local governments.

Report Scope

Feature of the Report Details
Market Size in 2023 USD 51.9 Billion
Projected Market Size in 2032 USD 165.5 Billion
Market Size in 2022 USD 49.3 Billion
CAGR Growth Rate 16.6% CAGR
Base Year 2023
Forecast Period 2024-2033
Key Segment By Product, Application and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

CMI has comprehensively analyzed the Global Polymeric Biomaterials market. The driving forces, restraints, challenges, opportunities, and key trends have been explained in depth to depict depth scenarios of the market. Segment wise market size and market share during the forecast period are duly addressed to portray the probable picture of this Global Polymeric Biomaterials industry.

The competitive landscape includes key innovators, after market service providers, market giants as well as niche players are studied and analyzed extensively concerning their strengths, weaknesses as well as value addition prospects. In addition, this report covers key players profiling, market shares, mergers and acquisitions, consequent market fragmentation, new trends and dynamics in partnerships.

Global Polymeric Biomaterials Market 2023–2032 (By Billion)

List of the prominent players in the Polymeric Biomaterials Market:

  • Stryker
  • Evonik Industries AG
  • DSM
  • Bezwada Biomedical LLC
  • Corbion
  • Invibio Ltd.
  • International Polymer Engineering
  • Covalon Technologies Ltd.
  • Medtronic
  • Abbott
  • Elixir Medical
  • REVA Medical LLC
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • DuPont de Nemours Inc.
  • Celanese Corporation
  • Covestro AG
  • Collagen Matrix Inc.
  • Others

The Polymeric Biomaterials Market is segmented as follows:

By Product

  • Polylactic Acid
  • Polyglycolic Acid
  • Polyurethanes
  • Polytetrafluoroethylene
  • Polyaryletheretherketone
  • Polydioxanone
  • Others

By Application

  • Cardiovascular
  • Dental
  • Orthopaedic
  • Plastic Surgery
  • Neurology
  • Other

Regional Coverage:

North America

  • U.S.
  • Canada
  • Mexico
  • Rest of North America


  • Germany
  • France
  • U.K.
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • New Zealand
  • Australia
  • South Korea
  • Taiwan
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America